Bremelanotide Acetate

Bremelanotide is a melanocortin receptor (MCR) agonist that nonselectively activates several receptor subtypes with the following order of potency: MC1R, MC4R, MC3R, MC5R, MC2R. At therapeutic dose levels, binding to MC1R and MC4R is most relevant. Neurons expressing MC4R are present in many areas of the central nervous system (CNS). The mechanism by which VYLEESI improves HSDD in women is unknown. The MC1R is expressed on melanocytes; binding at this receptor leads to melanin expression and increased pigmentation. Bremelanotide was approved in 6/21/2018 To treat hypoactive sexual desire disorder in premenopausal women.

Online Inquiry

Specification Technical Data Related Products Customer reviews and Q&A Useful Tools Publications

CAT#	R1960
Chemical Structure
CAS	1607799-13-2
Synonyms/Alias	Bremelanotide acetate; Bremelanotide; PT 141 acetate; PT-141 acetate; PT141 acetate
Chemical Formula	(3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid;acetic acid
M.F/Formula	C52H72N14O12
M.W/Mr.	1085.2
Sequence	Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-OH.CH3CO2H
Appearance	Solid powder
Activity	Agonist
Biological Activity	Bremelanotide Acetate (PT-141 Acetate), a synthetic peptide analogue of α-MSH, is an agonist at melanocortin receptors including the MC3R and MC4R for the treatment of sexual dysfunction.
Target	Melanocortin Receptor

Length	7
InChI	InChI=1S/C50H68N14O10.C2H4O2/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32;1-2(3)4/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55);1H3,(H,3,4)/t35-,36-,37-,38+,39-,40-,41-;/m0./s1
InChI Key	MAYUSRUHXFWITM-GBRHMYBBSA-N
Canonical SMILES	CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C.CC(=O)O
Isomeric SMILES	CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C.CC(=O)O

CAT#	Product Name	M.W	Molecular Formula	Inquiry
R1311	CTTHWGFTLC, CYCLIC			Inquiry
R1368	G3-C12 TFA			Inquiry
R1811	PAR-4 Agonist Peptide, amide TFA			Inquiry
R1259	Calcineurin substrate			Inquiry
R1728	Transdermal Peptide			Inquiry

Write a review Ask a question

My Review for Bremelanotide Acetate

Required fields are marked with *

• Review Headline *
• Comments *
• Basic Information
• Name
• Email *
• Phone
• Submit

×

Ask a Question for Bremelanotide Acetate

Required fields are marked with *

• Question *
• Basic Information
• Name
• Email *
• Phone
• Submit

×

Peptide Calculator

Abbreviation List

Peptide Glossary

Purity

Technical Support

Peptide Guide

FAQ

1. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

2. TMEM16F and dynamins control expansive plasma membrane reservoirs

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

5. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis